Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Observer-blinded, Active-controlled, Phase Illb Study to Compare IV / Oral Delafloxacin Fixed-dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections

NCT04042077 is registered in ClinicalTrials.gov with Menarini Group as lead sponsor.

NCT NCT04042077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04042077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Observer-blinded, Active-controlled, Phase Illb Study to Compare IV / Oral Delafloxacin Fixed-dose Monotherapy With Best Available Treatments in a Microbiologically Enriched Population With Surgical Site Infections
Lead sponsor
Menarini Group
Phase
Phase 3
Overall status
Terminated
Start date
September 25, 2019
Completion date
October 28, 2020
Enrollment
268 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surgical site infection